From the Journals

Ergonomic consultation spares endoscopists a pain in the neck


 

FROM GASTROINTESTINAL ENDOSCOPY

Recognition of the value of ergonomics is rising

“Endoscopy related injury and disability is a known hazard of our profession,” said Gyanprakash A. Ketwaroo, MD, of Baylor College of Medicine, Houston, in an interview. “Any studies to assess and, more importantly, offer ways to prevent such injury are immediately relevant. In this context, ergonomics for endoscopy is an increasing area of research.”

Dr. Ketwaroo said that the study results were not surprising. “I agree with authors that there is a paucity of general ergonomic training and assessment. Specific individualized wellness plans are rare. Developing an individual plan based on observation by physical therapists, and taking into account baseline injury or predisposition to injury would be expected to be more high yield for preventing injury and improving performance

“I believe the main take-home message from the study is that an individualized ergonomic plan based on assessment and feedback by physical therapists appears promising for optimizing endoscopic performance to minimize injury and reduce fatigue,” Dr. Ketwaroo said. However, “long-term studies in much larger samples will be needed to document objective findings of reduced injury or fatigue.”

The study received no outside funding. The researchers had no financial conflicts to disclose. Dr. Ketwaroo serves on the GI & Hepatology News editorial advisory board.

Pages

Recommended Reading

COVID-19 may alter gut microbiota
MDedge Internal Medicine
Incidence of autoimmune hepatitis may be rising
MDedge Internal Medicine
Defining wellness in IBD
MDedge Internal Medicine
High cost of pancreatic enzymes a barrier for patients with cancer
MDedge Internal Medicine
Tofacitinib for RA misses the mark in safety study
MDedge Internal Medicine
AGA Clinical Practice Update: Diagnosis and management of immune checkpoint inhibitor enterocolitis and hepatitis
MDedge Internal Medicine
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
MDedge Internal Medicine
AGA Clinical Practice Update: Bariatric surgery in patients with cirrhosis
MDedge Internal Medicine
Vedolizumab looks safer than anti-TNF drugs in older adults with IBD
MDedge Internal Medicine
Checkpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseases
MDedge Internal Medicine